Ad26: Phase I/IIa started
Johnson & Johnson’s Janssen Vaccines & Prevention B.V. unit began a double-blind, placebo-controlled, international Phase I/IIa trial
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
Johnson & Johnson’s Janssen Vaccines & Prevention B.V. unit began a double-blind, placebo-controlled, international Phase I/IIa trial